{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T23:34:58Z","timestamp":1649115298231},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,16]],"date-time":"2009-12-16T00:00:00Z","timestamp":1260921600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00292-009-1242-0","type":"journal-article","created":{"date-parts":[[2009,12,14]],"date-time":"2009-12-14T07:51:11Z","timestamp":1260777071000},"page":"42-49","source":"Crossref","is-referenced-by-count":0,"title":["Grauzonenlymphome"],"prefix":"10.1007","volume":"31","author":[{"given":"S.","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.L.","family":"Hansmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,16]]},"reference":[{"key":"1242_CR1","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE et al (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403:503\u2013511","journal-title":"Nature"},{"key":"1242_CR2","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1470-2045(02)00714-3","volume":"3","author":"Barth","year":"2002","unstructured":"Barth TF, Leithauser F, Joos S et al (2002) Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol 3:229\u2013234","journal-title":"Lancet Oncol"},{"key":"1242_CR3","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1084\/jem.20080809","volume":"205","author":"Brune","year":"2008","unstructured":"Brune V, Tiacci E, Pfeil I et al (2008) Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis. J Exp Med 205:2251\u20132268","journal-title":"J Exp Med"},{"key":"1242_CR4","doi-asserted-by":"crossref","first-page":"5494","DOI":"10.1158\/1078-0432.CCR-09-0113","volume":"15","author":"Choi","year":"2009","unstructured":"Choi WW, Weisenburger DD, Greiner TC et al (2009) A new immunostain algorithm classifies diffuse large B-cell lymphoma into molecular subtypes with high accuracy. Clin Cancer Res 15:5494\u20135502","journal-title":"Clin Cancer Res"},{"key":"1242_CR5","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2141.2006.06194.x","volume":"134","author":"Cogliatti","year":"2006","unstructured":"Cogliatti SB, Novak U, Henz S et al (2006) Diagnosis of Burkitt lymphoma in due time: a practical approach. Br J Haematol 134:294\u2013301","journal-title":"Br J Haematol"},{"key":"1242_CR6","doi-asserted-by":"crossref","unstructured":"Copie-Bergman C, Gaulard P, Leroy K et al (2009) Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: A GELA Study. J Clin Oncol","DOI":"10.1200\/JCO.2009.22.7058"},{"key":"1242_CR7","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, Bastian BC (2006) Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 24:4340\u20134346","journal-title":"J Clin Oncol"},{"key":"1242_CR8","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1093\/annonc\/mdn169","volume":"19","author":"Gravalos","year":"2008","unstructured":"Gravalos C, Jimeno A (2008) HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol 19:1523\u20131529","journal-title":"Ann Oncol"},{"key":"1242_CR9","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","volume":"103","author":"Hans","year":"2004","unstructured":"Hans CP, Weisenburger DD, Greiner TC et al (2004) Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103:275\u2013282","journal-title":"Blood"},{"key":"1242_CR10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3324\/haematol.12875","volume":"93","author":"Hartmann","year":"2008","unstructured":"Hartmann S, Martin-Subero JI, Gesk S et al (2008) Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin\u2019s lymphoma by array-based comparative genomic hybridization. Haematol 93:1318\u20131326","journal-title":"Haematol"},{"key":"1242_CR11","doi-asserted-by":"crossref","unstructured":"Hasserjian RP, Ott G, Elenitoba-Johnson KS et al (2009) Commentary on the WHO classification of tumors of lymphoid tissues (2008): \u201eGray zone\u201c lymphomas overlapping with Burkitt lymphoma or classical Hodgkin lymphoma. J Hematop","DOI":"10.1007\/s12308-009-0039-7"},{"key":"1242_CR12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/MCB.9.3.1165","volume":"9","author":"Hudziak","year":"1989","unstructured":"Hudziak RM, Lewis GD, Winget M et al (1989) p185HER2 monoclonal antibody has antiproliferative effects in vitro and sensitizes human breast tumor cells to tumor necrosis factor. Mol Cell Biol 9:1165\u20131172","journal-title":"Mol Cell Biol"},{"key":"1242_CR13","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa055351","volume":"354","author":"Hummel","year":"2006","unstructured":"Hummel M, Bentink S, Berger H et al (2006) A biologic definition of Burkitt\u2019s lymphoma from transcriptional and genomic profiling. N Engl J Med 354:2419\u20132430","journal-title":"N Engl J Med"},{"key":"1242_CR14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.10845","volume":"103","author":"Joos","year":"2003","unstructured":"Joos S, Granzow M, Holtgreve-Grez H et al (2003) Hodgkin\u2019s lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2. Int J Cancer 103:489\u2013495","journal-title":"Int J Cancer"},{"key":"1242_CR15","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1182\/blood.V87.4.1571.bloodjournal8741571","volume":"87","author":"Joos","year":"1996","unstructured":"Joos S, Otano-Joos MI, Ziegler S et al (1996) Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood 87:1571\u20131578","journal-title":"Blood"},{"key":"1242_CR16","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1038\/leu.2008.230","volume":"22","author":"Klapper","year":"2008","unstructured":"Klapper W, Stoecklein H, Zeynalova S et al (2008) Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL). Leukemia 22:2226\u20132229","journal-title":"Leukemia"},{"key":"1242_CR17","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","volume":"341","author":"K\u00fcppers","year":"1999","unstructured":"K\u00fcppers R, Klein U, Hansmann M-L, Rajewsky K (1999) Cellular origin of human B-cell lymphomas. N Engl J Med 341:1520\u20131529","journal-title":"N Engl J Med"},{"key":"1242_CR18","doi-asserted-by":"crossref","first-page":"10962","DOI":"10.1073\/pnas.91.23.10962","volume":"91","author":"K\u00fcppers","year":"1994","unstructured":"K\u00fcppers R, Rajewsky K, Zhao M et al (1994) Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development. Proc Natl Acad Sci U S A 91:10962\u201310966","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1242_CR19","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3324\/haematol.11305","volume":"92","author":"Le","year":"2007","unstructured":"Le Gouill S, Talmant P, Touzeau C et al (2007) The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24\/c-MYC rearrangement. Haematologica 92:1335\u20131342","journal-title":"Haematologica"},{"key":"1242_CR20","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1056\/NEJMoa0802885","volume":"359","author":"Lenz","year":"2008","unstructured":"Lenz G, Wright G, Dave SS et al (2008) Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 359:2313\u20132323","journal-title":"N Engl J Med"},{"key":"1242_CR21","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/path.2410","volume":"216","author":"Leucci","year":"2008","unstructured":"Leucci E, Cocco M, Onnis A et al (2008) MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation. J Pathol 216:440\u2013450","journal-title":"J Pathol"},{"key":"1242_CR22","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","volume":"105","author":"Melzner","year":"2005","unstructured":"Melzner I, Bucur AJ, Bruderlein S et al (2005) Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 105:2535\u20132542","journal-title":"Blood"},{"key":"1242_CR23","doi-asserted-by":"crossref","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","volume":"114","author":"Mottok","year":"2009","unstructured":"Mottok A, Renne C, Seifert M et al (2009) Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B cell lymphoma entities. Blood 114:4503\u20134506","journal-title":"Blood"},{"key":"1242_CR24","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","volume":"110","author":"Mottok","year":"2007","unstructured":"Mottok A, Renne C, Willenbrock K et al (2007) Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood 110:3387\u20133390","journal-title":"Blood"},{"key":"1242_CR25","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.1182\/blood-2006-09-047068","volume":"109","author":"Nyman","year":"2007","unstructured":"Nyman H, Adde M, Karjalainen-Lindsberg ML et al (2007) Prognostic impact of immunohistochemically defined germinal center phenotype in diffuse large B-cell lymphoma patients treated with immunochemotherapy. Blood 109:4930\u20134935","journal-title":"Blood"},{"key":"1242_CR26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0002-9440(10)63815-1","volume":"162","author":"Pileri","year":"2003","unstructured":"Pileri SA, Gaidano G, Zinzani PL et al (2003) Primary mediastinal B-cell lymphoma: high frequency of BCL-6 mutations and consistent expression of the transcription factors OCT-2, BOB.1 and PU.1 in the absence of immunoglobulins. Am J Pathol 162:243\u2013253","journal-title":"Am J Pathol"},{"key":"1242_CR27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/sj.leu.2404594","volume":"21","author":"Renn\u00e9","year":"2007","unstructured":"Renn\u00e9 C, Willenbrock K, Martin-Subero JI et al (2007) High expression of several tyrosine kinases and activation of the PI3\u00a0K\/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. Leukemia 21:780\u2013787","journal-title":"Leukemia"},{"key":"1242_CR28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa0904554","volume":"361","author":"Rosell","year":"2009","unstructured":"Rosell R, Moran T, Queralt C et al (2009) Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med 361:958\u2013967","journal-title":"N Engl J Med"},{"key":"1242_CR29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","volume":"198","author":"Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Leroy K et al (2003) Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma. J Exp Med 198:851\u2013862","journal-title":"J Exp Med"},{"key":"1242_CR30","doi-asserted-by":"crossref","unstructured":"Ross JS, Fletcher JA (1998) The HER-2\/neu oncogene in breast cancer: prognostic factor, predictive factor and target for therapy. Stem cells (Dayton, Ohio) 16:413\u2013428","DOI":"10.1002\/stem.160413"},{"key":"1242_CR31","doi-asserted-by":"crossref","first-page":"3533","DOI":"10.1182\/blood-2009-05-220095","volume":"114","author":"Savage","year":"2009","unstructured":"Savage KJ, Johnson NA, Ben-Neriah S et al (2009) MYC gene re-arrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy. Blood 114:3533\u20133537","journal-title":"Blood"},{"key":"1242_CR32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1084\/jem.20090528","volume":"206","author":"Schmitz","year":"2009","unstructured":"Schmitz R, Hansmann ML, Bohle V et al (2009) TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma. J Exp Med 206:981\u2013989","journal-title":"J Exp Med"},{"key":"1242_CR33","unstructured":"Swerdlow SH, International Agency for Research on Cancer, World Health Organization (2008) WHO classification of tumours of haematopoietic and lymphoid tissues. International Agency for Research on Cancer, Lyon, France"},{"key":"1242_CR34","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","volume":"29","author":"Traverse-Glehen","year":"2005","unstructured":"Traverse-Glehen A, Pittaluga S, Gaulard P et al (2005) Mediastinal gray zone lymphoma: the missing link between classic Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol 29:1411\u20131421","journal-title":"Am J Surg Pathol"},{"key":"1242_CR35","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2353\/jmoldx.2006.050083","volume":"8","author":"Ventura","year":"2006","unstructured":"Ventura RA, Martin-Subero JI, Jones M et al (2006) FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 8:141\u2013151","journal-title":"J Mol Diagn"},{"key":"1242_CR36","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1470-2045(05)70097-8","volume":"6","author":"Wardelmann","year":"2005","unstructured":"Wardelmann E, Thomas N, Merkelbach-Bruse S et al (2005) Acquired resistance to imatinib in gastrointestinal stromal tumours caused by multiple KIT mutations. Lancet Oncol 6:249\u2013251","journal-title":"Lancet Oncol"},{"key":"1242_CR37","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1038\/sj.onc.1209151","volume":"25","author":"Weniger","year":"2006","unstructured":"Weniger MA, Melzner I, Menz CK et al (2006) Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene 25:2679\u20132684","journal-title":"Oncogene"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-009-1242-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-009-1242-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-009-1242-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T06:55:05Z","timestamp":1590303305000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-009-1242-0"}},"subtitle":["Relevanz f\u00fcr die Klinik?"],"short-title":[],"issued":{"date-parts":[[2009,12,16]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1007\/s00292-009-1242-0","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"value":"0172-8113","type":"print"},{"value":"1432-1963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,16]]}}}